bibliographicCitation |
He J, He D, Han X, Zheng G, Wei G, Zhao Y, Yang Y, Wu W, Fu J, Shou L, Kong H, Huang H, Cai Z. Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data. Front Pharmacol. 2020;11():561601. PMID: 33362538; PMCID: PMC7759685. |